Country
Belgium
A coronavirus vaccine developed by Oxford University and AstraZeneca Plc was approved by the European Commission on 29 January, only hours after the European Medicines Agency gave the product a positive opinion. The approval is the third for a Covid-19 vaccine in the EU.
Full text available to subscribers only. Click here for information on subscribing to MedNous.